Enhanced Recovery Protocol for Anorectal Surgery
“Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery”
The purpose of the study is to evaluate whether being randomized to an aggressive postoperative non-narcotic pain regimen that treats pain from multiple different pathways may decrease postoperative pain levels, decrease constipation, and decrease the dependency on opioid medications after anorectal surgery versus the standard of care for managing pain. This use of a more aggressive pain regimen is considered an enhanced recovery after surgery (ERAS) protocol because it is theorized to improve or "enhance" postoperative recovery by both decreasing the use of narcotics and their detrimental effects as well as increasing the benefit of using additional non-narcotic pain medication.
Combination Product - ERAS
Gabapentin Acetaminophen Ketoroloac IV (intraop) and PO Dexamethasone (included with benzocaine in local anesthesia) Oxycodone PO Polyethylene glycol
Combination Product - Standard of care
Oxcodone PO Ketorolac IV only (intraop)
Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery